The author of 《Hybrid molecules of scutellarein and tertramethylpyrazine’s active metabolites for ischemic stroke》 were Dong, Yongxi; Zhang, Xiaohe; Liu, Mingji; Yang, Yang; Guo, Ting; Mao, Yuanhu; Zhang, Jiquan; Fu, Xiaozhong; Zhao, Yonglong; Chen, Jinglei; Dong, Li; Qiao, Chunhua. And the article was published in Bioorganic & Medicinal Chemistry Letters in 2019. Quality Control of 4-Bromobutanoic acid The author mentioned the following in the article:
A series of hybrid mols. of scutellarein and tertramethylpyrazine’s active metabolites have been synthesized. Compared to the original compound, these prepared compounds exhibited higher water solubility, more appropriate logP and better stability. Importantly, compounds I [R = Me, iBu, sec-Bu] showed improved neuroprotective activity against the H2O2-induced cell death in PC12 cells, and better antithrombosis activity. The optimized compound I [R = Me] was further evaluated by cerebral ischemia/ reperfusion in the middle cerebral artery occlusion (MCAO) model, the results showed that the compound could significantly reduce the infarct area and decrease the neuronal cell damage in CA1 pyramidal neurons. Overall, we demonstrated that the twin drug strategy could be applied in the development of agents for the treatment of ischemic stroke. In the experimental materials used by the author, we found 4-Bromobutanoic acid(cas: 2623-87-2Quality Control of 4-Bromobutanoic acid)
4-Bromobutanoic acid(cas: 2623-87-2) belongs to carboxylic acids. The chief chemical characteristic of the carboxylic acids is their acidity. They are generally more acidic than other organic compounds containing hydroxyl groups but are generally weaker than the familiar mineral acids (e.g., hydrochloric acid, HCl, sulfuric acid, H2SO4, etc.).Quality Control of 4-Bromobutanoic acid
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary